John Paulson's MDGL Position Overview
John Paulson (via Paulson & Co. Inc.) currently holds 1.71 M shares of Madrigal Pharmaceuticals, Inc. (MDGL) worth $994.36 M, representing 30.48% of the portfolio. First purchased in 2023-Q2, this medium-term investment has been held for 11 quarters.
Based on 13F filings, John Paulson has maintained a strategic position in MDGL, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2024, adding 669,259 shares. Largest reduction occurred in Q4 2025, reducing 200,001 shares.
Analysis based on 13F filings available since 2013 Q2
John Paulson's Madrigal Pharmaceuticals (MDGL) Holding Value Over Time
Track share changes against reported price movement
Quarterly Madrigal Pharmaceuticals (MDGL) Trades by John Paulson
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -200,001 | Reduce 10.48% | 1.71 M | $582.34 |
| Q3 2025 | -182,000 | Reduce 8.71% | 1.91 M | $458.66 |
| Q2 2025 | -10,000 | Reduce 0.48% | 2.09 M | $302.64 |
| Q1 2025 | +57,523 | Add 2.82% | 2.1 M | $331.23 |
| Q3 2024 | +192,000 | Add 10.38% | 2.04 M | $192.27 |
| Q2 2024 | +75,000 | Add 4.23% | 1.85 M | $280.16 |
| Q1 2024 | +669,259 | Add 60.53% | 1.78 M | $267.04 |
| Q4 2023 | +605,741 | Add 121.15% | 1.11 M | $231.38 |
| Q3 2023 | +149,800 | Add 42.78% | 500,000 | $146.04 |
| Q2 2023 | +350,200 | New Buy | 350,200 | $231.00 |
John Paulson's Madrigal Pharmaceuticals Investment FAQs
John Paulson first purchased Madrigal Pharmaceuticals, Inc. (MDGL) in Q2 2023, acquiring 350,200 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
John Paulson has held Madrigal Pharmaceuticals, Inc. (MDGL) for 11 quarters since Q2 2023.
John Paulson's largest addition to Madrigal Pharmaceuticals, Inc. (MDGL) was in Q1 2024, adding 1,775,000 shares worth $474 M.
According to the latest 13F filing for Q4 2025, John Paulson's firm, Paulson & Co. Inc., owns 1,707,522 shares of Madrigal Pharmaceuticals, Inc. (MDGL), valued at approximately $994.36 M.
As of the Q4 2025 filing, Madrigal Pharmaceuticals, Inc. (MDGL) represents approximately 30.48% of John Paulson's publicly disclosed stock portfolio, making it one of their key holdings.
John Paulson's peak holding in Madrigal Pharmaceuticals, Inc. (MDGL) was 2,099,523 shares, as reported at the end of Q1 2025.